These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1098 related items for PubMed ID: 12910596

  • 1. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G.
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [Abstract] [Full Text] [Related]

  • 2. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M.
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [Abstract] [Full Text] [Related]

  • 3. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC, Burgess MA, O'Brien ED.
    Commun Dis Intell; 1998 Aug 06; 22(8):159. PubMed ID: 9735551
    [No Abstract] [Full Text] [Related]

  • 4. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
    Sáenz González MC, Núñez Mateos JC, Rodrigo Sánchez N, Martín Sánchez AM.
    An Esp Pediatr; 1992 Apr 06; 36(4):293-7. PubMed ID: 1605414
    [Abstract] [Full Text] [Related]

  • 5. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W.
    Przegl Epidemiol; 1993 Apr 06; 47(1-2):47-53. PubMed ID: 8351387
    [Abstract] [Full Text] [Related]

  • 6. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 7. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K.
    N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278
    [Abstract] [Full Text] [Related]

  • 8. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan 24; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 9. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M, Christenson B, Strandell A, Romanus V.
    Dev Biol Stand; 1986 Jan 24; 65():37-43. PubMed ID: 3556776
    [Abstract] [Full Text] [Related]

  • 10. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P.
    Ann Ig; 1998 Jan 24; 10(1):19-24. PubMed ID: 9616974
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 24; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 12. [Field trial with a new human diploid cell vaccine (HDCV) against measles, mumps and rubella].
    Just M, Berger R, Glück R, Wegmann A.
    Schweiz Med Wochenschr; 1985 Nov 30; 115(48):1727-30. PubMed ID: 4081704
    [Abstract] [Full Text] [Related]

  • 13. Measles, mumps and rubella: control by vaccination.
    van Druten JA, de Boo T, Plantinga AD.
    Dev Biol Stand; 1986 Nov 30; 65():53-63. PubMed ID: 3556777
    [Abstract] [Full Text] [Related]

  • 14. A field trial of combined measles-mumps-rubella vaccine. Satisfactory immunization with 188 children in Chile.
    Borgoño JM, Greiber R, Solari G, Concha F, Carrillo B, Hilleman MR.
    Clin Pediatr (Phila); 1973 Mar 30; 12(3):170-2. PubMed ID: 4701464
    [No Abstract] [Full Text] [Related]

  • 15. [Epidemiologic study of measles, rubella and mumps with regard to the possibility of their control by immunization].
    Rodríguez Borrego MJ, García León J, Bolumar F, Nájera E.
    Rev Sanid Hig Publica (Madr); 1985 Mar 30; 59(1-2):117-25. PubMed ID: 4059834
    [No Abstract] [Full Text] [Related]

  • 16. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A, Giorgi-Rossi P, Sangalli M, Spadea T, Perucci CA.
    Ann Ig; 2002 Mar 30; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract] [Full Text] [Related]

  • 17. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G.
    Minerva Pediatr; 1989 Mar 30; 41(3):117-22. PubMed ID: 2747598
    [Abstract] [Full Text] [Related]

  • 18. [Vaccination against measles, mumps and German measles. I. Medical and epidemiological aspects].
    Bjerregaard P, Pedersen KM, Kamper-Jørgensen F, Koch C, Pedersen FK, Wagner AL, Zoffmann H.
    Ugeskr Laeger; 1985 Sep 16; 147(38):3013-7. PubMed ID: 4071749
    [No Abstract] [Full Text] [Related]

  • 19. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE, Buynak EB, Stokes J, Hilleman MR.
    Pediatrics; 1973 Mar 16; 51(3):467-75. PubMed ID: 4707864
    [No Abstract] [Full Text] [Related]

  • 20. Combined administration of measles, mumps, rubella, and trivalent oral poliovirus vaccines.
    Krugman RD, Witte JJ, Parkman PD, Herrmann KL, Meyer HM, Wende RD, Meyer BC, Dungca R.
    Public Health Rep; 1977 Mar 16; 92(3):220-2. PubMed ID: 866558
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.